Role of rituximab in the first-line therapy of high-risk diffuse large B-cell lymphoma: a retrospective analysis by the Polish Lymphoma Research Group
Wojciech Jurczak, Bogdan Ochrem, Agnieszka Giza, Dagmara Zimowska-Curyło, Tomasz Górecki, Piotr Boguradzki, Wanda Knopińska-Posłuszny, Beata Stella-Hołowiecka, Jan Walewski, Monika Joks, Tomasz Wróbel, Jan M. Zaucha